First Molecular Genetic Characterization of Skene's Gland Adenocarcinoma.
PTEN gene
Skene’s gland adenocarcinoma
molecular genetics
next-generation sequencing
paraurethral glands
Journal
International journal of surgical pathology
ISSN: 1940-2465
Titre abrégé: Int J Surg Pathol
Pays: United States
ID NLM: 9314927
Informations de publication
Date de publication:
Jun 2021
Jun 2021
Historique:
pubmed:
17
8
2020
medline:
8
9
2021
entrez:
16
8
2020
Statut:
ppublish
Résumé
Primary urethral adenocarcinomas are very rare neoplasms accounting for <10% of all urethral carcinomas. Site of their origin is unclear, but they seem to arise from Skene's paraurethral glands, which is the female homologue of the male prostate. The aim of this article is to report the first case of Skene's gland adenocarcinoma in which a molecular genetic profiling was performed. The patient was a 73-year-old woman with a polypoid lesion sized 3 × 2 cm located at the interface between the bladder neck and the proximal urethra. Transurethral resection was performed and small tissue fragments with positive margins were obtained. Histology revealed an epithelial neoplasm consisting of cribriform structures located in the subepithelial connective tissue of the bladder wall and proximal urethra. The lesion showed positive immunohistochemical staining with prostate specific antigen, prostatic acid phosphatase, NKX3.1, and alpha-methylacyl-CoA racemase. Using the Illumina TruSight Tumor 170 next-generation sequencing assay, a mutation and loss of heterozygosity of the phosphatase and tensin homologue (
Identifiants
pubmed: 32795117
doi: 10.1177/1066896920947808
doi:
Substances chimiques
Biomarkers, Tumor
0
PTEN Phosphohydrolase
EC 3.1.3.67
PTEN protein, human
EC 3.1.3.67
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM